Medical Information Technology Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Medical Information Technology Inc (MITII) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Medical Information Technology Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 512M vs 346M combined for its competitors (59.7% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-10.3% annualized vs trailing 12 months), vs decelerating (-21.0%) for its tracked peer group.
- Growth: Medical Information Technology Inc generated -5.4% revenue growth year over year in Q3 2020, vs -0.5% for its competitors combined.
- Profitability: Its 26.7% net margin compares with 7.7% for the peer group.
- Peer revenue share: Medical Information Technology Inc accounted for 62.7% of combined revenue among its tracked peer group, down from 63.8% a year earlier.
- Peer differentiation: Revenue per employee of $0.14M compares with $0.10M for the peer group (1.4x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
MITII Sales vs. its Competitors, Q3 2020
Medical Information Technology Inc reported revenue contraction of 5.35 % year on year in Q3 2020, below its competitors' combined revenue change of -0.53 %.
With a net margin of 26.69 %, Medical Information Technology Inc achieved higher profitability than its competitors (7.71 %).
Medical Information Technology Inc generated 62.67 % of the combined sales of its peer group, down from 63.82 % a year earlier.
API endpoints for this dataset
Medical Information Technology Inc vs. its Competitors, Q3 2020
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Medical Information Technology Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Medical Information Technology Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Medical Information Technology Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (3) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (8) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Medical Information Technology Inc's competitor groups requires a Commercial License.
For context: the Software & Programming industry grew revenue 16.7% year over year, combined, vs -5.4% for Medical Information Technology Inc. Medical Information Technology Inc's share of combined industry revenue moved from 0.04% to 0.04%, a loss of 0.01 percentage points.
Medical Information Technology Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Medical Information Technology Inc | Yes | Yes | No | No |
| Competitors combined (1) | ||||
| High-Confidence Competitors (3) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 0.00 % (0 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
MITII Stock Performance relative to its Competitors
MITII Stock Performance relative to High-Confidence Competitors
MITII Stock Performance relative to Similar Growth & Profitability Competitors
Publicly Traded Peers of Medical Information Technology Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Medical Information Technology Inc |
- | 511.50 |
 Trubridge Inc |
382.19 | 345.90 |
| SUBTOTAL | 382.19 | 857.40 |
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Medical Information Technology Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Medical Information Technology Inc's Competitors Named by the Company
Competitive relationships identified from Medical Information Technology Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Cerner Corporation | Company report | 85% |
| Trubridge Inc | Company report | 85% |
| Veradigm Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Medical Information Technology Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Medical Information Technology Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Trubridge Inc | Financial Health 61.75 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Medical Information Technology Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Medical Information Technology Inc | - | 138,244 | 20,181 |
| Trubridge Inc | 382 | 98,828 | 1,257 |
| PEERS TOTAL | 382 | 98,828 | 1,257 |
Medical Information Technology Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Software & Programming industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (442 companies). See the full Software & Programming industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 0.00 % | 50.50 % (avg) | -50.5 pp |
| Operating Margin | 17.68 % | industry median | +23.2 pp |
| EBITDA Margin | 18.40 % | 1.87 % (avg) | +16.5 pp |
| Capital Intensity (Capex / Revenue) | 0.72 % | 5.22 % (avg) | -4.5 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Medical Information Technology Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2017 | 2018 | 2019 |
|---|---|---|---|
| Revenue Growth | 0.86 % | 2.05 % | 0.97 % |
| Operating Margin | 11.79 % | 13.27 % | 13.52 % |
| Return on Invested Capital | 5.36 % | 6.63 % | 6.36 % |
| P/E | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Medical Information Technology Inc's Strategic Group Map
Medical Information Technology Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Medical Information Technology Inc's trailing-12-month revenue growth of 7.2% and operating margin of 17.7% compares with an average of 7.1% growth and 17.5% margin across its 8 closest peers by combined growth, margin and ROIC -- Medical Information Technology Inc sits above that peer average on growth and above it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Medical Information Technology Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.72 % vs industry average 5.22 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Medical Information Technology Inc's dedicated Suppliers and Customers pages, not here.
Medical Information Technology Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Medical Information Technology Inc falls in the Low attractiveness / High strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Medical Information Technology Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 23.2 points above the industry median.
Weaknesses
- Return on equity 11.4 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-10.3% annualized vs trailing 12 months).
Opportunities
- Industry revenue growing at a healthy 11.3% median pace.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-21.0% annualized).
Methodology: see Methodology: SWOT Analysis.
Medical Information Technology Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Medical Information Technology Inc | 0.43 | 6.27 | - |
| Trubridge Inc | 0.41 | 1.82 | 0.93 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Medical Information Technology Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Medical Information Technology Inc | Q3 2020 | -5.3 % | -66.3 % |
| Trubridge Inc | Q1 2026 | -1.1 % | +10.2 % |
| PEERS TOTAL | -3.6 % | -65.9 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Medical Information Technology Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Medical Information Technology Inc | Q3 2020 | - | -38.7 % |
| Trubridge Inc | Q1 2026 | -3.9 % | -14.1 % |
Medical Information Technology Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Medical Information Technology Inc | 11.67% | 13.18% | 14.01% |
| Trubridge Inc | 1.10% | 1.28% | 2.48% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Medical Information Technology Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Medical Information Technology Inc | - | - |
| Trubridge Inc | 94.02 | 1.10 |
| PEERS AVERAGE | 4.83 | 0.45 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.